AwesomeCapital
Search This Blog
Monday, June 3, 2019
NextCure started at Overweight by Morgan Stanley
Target $25
https://www.benzinga.com/stock/NXTC/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.